medigraphic.com
SPANISH

Revista Cubana de Reumatología

ISSN 1817-5996 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 3

<< Back Next >>

Rev Cub de Reu 2021; 23 (3)

Gout as a cardiovascular risk factor

Hernández BSC, Villafuerte MJE, Chimbolema MSO, Pilamunga LCL
Full text How to cite this article

Language: Spanish
References: 12
Page:
PDF size: 339.63 Kb.


Key words:

cardiovascular disease, rheumatic disease, gout, arterial hypertension.

ABSTRACT

Introduction: Gout is a chronic inflammatory disease that generally progresses with added hyperuricemia.
Objective: To identify the presence of cardiovascular involvement in patients with a confirmed diagnosis of gouty arthropathy.
Methodology: A basic, non-experimental, descriptive, retrospective and mixed-focus research was developed. The universe consisted of 69 patients treated in first-level health care units in the city of Riobamba during the period between January 2019 and January 2021. The sample was made up of a total of 60 patients. A review of the clinical history of the patients was carried out to obtain the necessary information.
Result: Average age of 53.02 years. 35.00% of them presented at least one associated comorbidity, where diabetes mellitus was the most represented (57.14%). with presence of comorbidities. 71.67% of the patients had normal blood uric acid values at the time of diagnosis and 18.33% had some type of kidney damage. 36.67% of the patients with gout also presented cardiovascular disease, where arterial hypertension (59.09%) was the most frequently reported.
Conclusions: Gouty arthropathy is a disease that theoretically generates a high percentage of cardiovascular diseases within of which arterial hypertension and heart failure stand out.


REFERENCES

  1. Solis Cartas U, Bejarano S, Valdés González JL, Aguirre Saimeda GL. Necrosis avascular de la cabeza femoral en un paciente con gota. Rev Cuba Reumatol. 2018 [Acceso 28/05/2021];20(2):e14. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962018000200009&lng=es

  2. Ortiz Olivares AM, Cortés Ross OM, Torres Motas DM. Chronic tophaceous gout in an adult. MEDISAN. 2019 [Acceso 25/05/2021];23(1):114-20. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192019000100114&lng=es

  3. Machado Curbelo AJ, Amaro Méndez S. Gota, hiperuricemia e hiperlipoproteinemias. Rev Cubana Med. 2020 [Acceso 01/06/2021];16(4):[aprox. 7 p.]. Disponible en: Disponible en: http://www.revmedicina.sld.cu/index.php/med/article/view/1130

  4. Valdés González JL, Valdés González EM, Solis Cartas U, Sigcho Romero SF. Dengue, COVID-19 y gota, una asociación infrecuente. Rev Cubana Reumatol. 2020 [Acceso 30/05/2021];22(4 Extra.):[aprox. 9 p.]. Disponible en: Disponible en: http://revreumatologia.sld.cu/index.php/reumatologia/article/view/871

  5. Santillana-Marín RA, Múzquiz-Ramos EM, García-Cerda LA, Cruz-Ortíz BR. Bioactividad y pruebas de hemólisis de compósitos de hidroxiapatita zirconia (HAp/ZrO2-8Y2O3) para implantes óseos. Rev Mexicana Ingen Bioméd. 2020;39(3):262-70. DOI: https://doi.org/10.17488/rmib.39.3.5

  6. Valdés González JL, Paca Gualla MJ, González Benitez S, Freire Ramos ER. Patrón nutricional en pacientes con gota. Rev Cubana Reumatol . 2020 Dic [Acceso 26/05/2021];22(3):e780. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962020000300003&lng=es

  7. Chapalbay Parreño IC, Ayala Reinoso PP, Campos Ruiz LF, Orna Brito VH, Martínez Larrarte JP. Adherencia farmacológica en pacientes con enfermedades reumáticas. Rev Cubana Reumatol . 2019 [Acceso 03/06/2021];21(3):e99. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962019000300003&lng=es

  8. Vázquez Ávila JA, Zetina Martínez M, Duarte Mote J. Hiperuricemia e hipertensión arterial sistémica: ¿cuál es la relación? Med Interna Méx. 2018 [Acceso 29/05/2021];34(2):278-87. Disponible en: Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-48662018000200009&lng=es

  9. Lombas García M, Giral Casielles R, Mateo Suárez M, Moreno Mejías A, Castell Pérez C. Concepto, clasificación, diagnóstico y tratamiento de las artropatías. Rev Cubana Med . 2009 [Acceso 06/06/2021];13(6):[aprox. 8 p.]. Disponible en: Disponible en: http://revmedicina.sld.cu/index.php/med/article/view/368

  10. Vizcaino Luna Y, Bermúdez Marrero WM, Bermúdez Marrero WA, Egües Mesa JL, Cárdenas Domínguez T, Prendes García E. Gout Arthritis. Ten years of follow up. Rev Cubana Reumatol . 2019 [Acceso 02/06/2021];21(3):[aprox. 9 p.]. Disponible en: Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/717

  11. López-Rocha EG, Hernández-Montoya G, Rodríguez-Pesina AH, Rodríguez-Mireles KA. Desensibilización a alopurinol en paciente con gota tofácea. Rev Alerg Méx. 2018 [Acceso 02/06/2021];65(3):316-20. Disponible en: Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2448-91902018000300236&lng=es

  12. Leal Balón E, Arjona Rodríguez IA, Quiñones Milián IR, Massip Nicot J, Goberna Rocha M, Fernández Massip H. Perfil clínico y terapéutico en insuficiencia cardiaca aguda. Arch Hosp Univ “Gen. Calixto García”. 2020 [Acceso 03/06/2021];8(3):[aprox. 7 p.]. Disponible en: Disponible en: http://revcalixto.sld.cu/index.php/ahcg/article/view/536




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub de Reu. 2021;23